{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T15:29:10Z","timestamp":1775921350388,"version":"3.50.1"},"posted":{"date-parts":[[2023,2,27]]},"group-title":"Cancer Biology","reference-count":51,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,5,14]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:p>Taurine, a non-proteogenic amino acid, and commonly used nutritional supplement can protect various tissues from degeneration associated with the action of the DNA-damaging chemotherapeutic agent cisplatin. Whether and how taurine protects human ovarian cancer (OC) cells from DNA damage caused by cisplatin is not well understood. We have found that OC ascites-derived cells contained significantly more intracellular taurine than cell cultures modeling OC. In culture, elevation of intracellular taurine concentration to OC ascites-cells-associated levels suppressed proliferation of various OC cell lines and patient-derived organoids, reduced glycolysis, and induced cell protection from cisplatin. Taurine cell protection was associated with decreased DNA damage in response to cisplatin. A combination of RNA sequencing, reverse phase protein arrays, live-cell microscopy, flow cytometry, and biochemical validation experiments provided evidence for taurine-mediated induction of mutant- or wild-type p53 binding to DNA, and activation of p53 effectors involved in negative regulation of the cell cycle (p21), and glycolysis (TIGAR). Paradoxically, taurine\u2019s suppression of cell proliferation was associated with activation of pro-mitogenic signal transduction including ERK, mTOR, and increased mRNA expression of major DNA damage sensing molecules such as DNAPK, ATM and ATR. While inhibition of ERK or p53 did not interfere with taurine\u2019s ability to protect cells from cisplatin, suppression of mTOR with Torin2, a clinically relevant inhibitor that also targets DNAPK and ATM\/ATR, broke taurine\u2019s cell protection. Our studies implicate that elevation of intracellular taurine could suppress cell growth, metabolism, and activate cell protective mechanisms involving mTOR and DNA damage sensing signal transduction.<\/jats:p>","DOI":"10.1101\/2023.02.24.529893","type":"posted-content","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T12:10:13Z","timestamp":1677499813000},"source":"Crossref","is-referenced-by-count":1,"title":["Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-damage-sensing-dependent Cell Protection"],"prefix":"10.64898","author":[{"given":"Daniel","family":"Centeno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadaf","family":"Farsinejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Kochetkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Volpari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Gladych-Macioszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Klupczynska \u2013 Gabryszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teagan","family":"Polotaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Kung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonja","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szymon","family":"Plewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helin","family":"Vakifahmetoglu-Norberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Frederick J","family":"Monsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A. J.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Matysiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikolaj","family":"Zaborowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Analisa","family":"DiFeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Norberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8375-8447","authenticated-orcid":false,"given":"Marcin","family":"Iwanicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"4","key":"2024051811050672000_2023.02.24.529893v4.1","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/hmg\/ddz303","article-title":"Taurine treatment of retinal degeneration and cardiomyopathy in a consanguineous family with SLC6A6 taurine transporter deficiency","volume":"29","year":"2020","journal-title":"Hum Mol Genet"},{"key":"2024051811050672000_2023.02.24.529893v4.2","unstructured":"Singh, P. , et al., Taurine deficiency as a driver of aging. Science, 2023. 380(6649): p. eabn9257."},{"issue":"2","key":"2024051811050672000_2023.02.24.529893v4.3","first-page":"57","article-title":"The potential health benefits of taurine in cardiovascular disease","volume":"13","year":"2008","journal-title":"Exp Clin Cardiol"},{"key":"2024051811050672000_2023.02.24.529893v4.4","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-024-1079-2_21"},{"key":"2024051811050672000_2023.02.24.529893v4.5","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2012.44.11.075"},{"key":"2024051811050672000_2023.02.24.529893v4.6","doi-asserted-by":"publisher","DOI":"10.1113\/JP271418"},{"issue":"6","key":"2024051811050672000_2023.02.24.529893v4.7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/biof.1301","article-title":"Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses","volume":"42","year":"2016","journal-title":"Biofactors"},{"key":"2024051811050672000_2023.02.24.529893v4.8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00274.2014"},{"key":"2024051811050672000_2023.02.24.529893v4.9","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2055"},{"key":"2024051811050672000_2023.02.24.529893v4.10","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2657"},{"issue":"1","key":"2024051811050672000_2023.02.24.529893v4.11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-016-0360-4","article-title":"TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia","volume":"9","year":"2016","journal-title":"J Hematol Oncol"},{"key":"2024051811050672000_2023.02.24.529893v4.12","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.3.10556"},{"issue":"18","key":"2024051811050672000_2023.02.24.529893v4.13","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1111\/j.1432-1033.2004.04319.x","article-title":"Structured DNA promotes phosphorylation of p53 by DNA-dependent protein kinase at serine 9 and threonine 18","volume":"271","year":"2004","journal-title":"Eur J Biochem"},{"key":"2024051811050672000_2023.02.24.529893v4.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.04.037"},{"key":"2024051811050672000_2023.02.24.529893v4.15","doi-asserted-by":"crossref","unstructured":"Maddocks, O.D. , et al., Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature, 2013. 493(7433): p. 542-6.","DOI":"10.1038\/nature11743"},{"key":"2024051811050672000_2023.02.24.529893v4.16","doi-asserted-by":"crossref","unstructured":"Ahmed, A.A. , et al., Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol. 221(1): p. 49\u201356.","DOI":"10.1002\/path.2696"},{"key":"2024051811050672000_2023.02.24.529893v4.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.11.004"},{"key":"2024051811050672000_2023.02.24.529893v4.18","doi-asserted-by":"crossref","unstructured":"Martincorena, I. , et al., Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science, 2015. 348(6237): p. 880-6.","DOI":"10.1126\/science.aaa6806"},{"key":"2024051811050672000_2023.02.24.529893v4.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0199-y"},{"key":"2024051811050672000_2023.02.24.529893v4.20","doi-asserted-by":"publisher","DOI":"10.1101\/gad.995802"},{"key":"2024051811050672000_2023.02.24.529893v4.21","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-18930-2_11"},{"key":"2024051811050672000_2023.02.24.529893v4.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2015.06.002"},{"issue":"1","key":"2024051811050672000_2023.02.24.529893v4.23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","year":"2023","journal-title":"Mol Cancer"},{"key":"2024051811050672000_2023.02.24.529893v4.24","doi-asserted-by":"crossref","unstructured":"Kong, N. , et al., Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition. Sci Transl Med, 2019. 11(523).","DOI":"10.1126\/scitranslmed.aaw1565"},{"key":"2024051811050672000_2023.02.24.529893v4.25","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-838-2:013"},{"key":"2024051811050672000_2023.02.24.529893v4.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103533"},{"key":"2024051811050672000_2023.02.24.529893v4.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0422-6"},{"key":"2024051811050672000_2023.02.24.529893v4.28","doi-asserted-by":"crossref","unstructured":"Alshehri, S. , et al., Extracellular Matrix Modulates Outgrowth Dynamics in Ovarian Cancer. Adv Biol (Weinh), 2022: p. e2200197.","DOI":"10.1101\/2022.01.30.478322"},{"key":"2024051811050672000_2023.02.24.529893v4.29","doi-asserted-by":"crossref","unstructured":"Iwanicki, M.P. , et al., Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. JCI Insight, 2016. 1(10).","DOI":"10.1172\/jci.insight.86829"},{"key":"2024051811050672000_2023.02.24.529893v4.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00962-1"},{"key":"2024051811050672000_2023.02.24.529893v4.31","doi-asserted-by":"publisher","DOI":"10.1002\/path.2696"},{"key":"2024051811050672000_2023.02.24.529893v4.32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205939200"},{"key":"2024051811050672000_2023.02.24.529893v4.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2015.11.020"},{"key":"2024051811050672000_2023.02.24.529893v4.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.01.018"},{"issue":"13","key":"2024051811050672000_2023.02.24.529893v4.35","first-page":"2910","article-title":"Topological control of p21WAF1\/CIP1 expression in normal and neoplastic tissues","volume":"55","year":"1995","journal-title":"Cancer Res"},{"key":"2024051811050672000_2023.02.24.529893v4.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.05.036"},{"issue":"16","key":"2024051811050672000_2023.02.24.529893v4.37","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1101\/gad.14.16.2072","article-title":"Hypersensitivity to DNA damage leads to increased apoptosis during early mouse development","volume":"14","year":"2000","journal-title":"Genes Dev"},{"key":"2024051811050672000_2023.02.24.529893v4.38","doi-asserted-by":"crossref","unstructured":"Tsunoda, T. , et al., Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines. Oncogene, 2005. 24(8): p. 1396-402.","DOI":"10.1038\/sj.onc.1208313"},{"key":"2024051811050672000_2023.02.24.529893v4.39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207164"},{"key":"2024051811050672000_2023.02.24.529893v4.40","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210086"},{"key":"2024051811050672000_2023.02.24.529893v4.41","doi-asserted-by":"crossref","unstructured":"Kang, H.C. , et al., Identification of genes with differential expression in acquired drug- resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res, 2004. 10(1 Pt 1): p. 272-84.","DOI":"10.1158\/1078-0432.CCR-1025-3"},{"key":"2024051811050672000_2023.02.24.529893v4.42","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1702"},{"issue":"64","key":"2024051811050672000_2023.02.24.529893v4.43","doi-asserted-by":"crossref","first-page":"107877","DOI":"10.18632\/oncotarget.14112","article-title":"The prognostic value of Ki67 in ovarian high-grade serous carcinoma: an 11-year cohort study of Chinese patients","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"2024051811050672000_2023.02.24.529893v4.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01230-9"},{"key":"2024051811050672000_2023.02.24.529893v4.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.11.009"},{"key":"2024051811050672000_2023.02.24.529893v4.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.12.012"},{"issue":"1","key":"2024051811050672000_2023.02.24.529893v4.47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00726-017-2499-x","article-title":"Taurine as a water structure breaker and protein stabilizer","volume":"50","year":"2018","journal-title":"Amino Acids"},{"issue":"29","key":"2024051811050672000_2023.02.24.529893v4.48","doi-asserted-by":"crossref","first-page":"25844","DOI":"10.1021\/acsomega.2c03479","article-title":"Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics","volume":"7","year":"2022","journal-title":"ACS Omega"},{"issue":"6","key":"2024051811050672000_2023.02.24.529893v4.49","doi-asserted-by":"crossref","first-page":"e108946","DOI":"10.15252\/embj.2021108946","article-title":"Pharmacological CDK4\/6 inhibition reveals a p53-dependent senescent state with restricted toxicity","volume":"41","year":"2022","journal-title":"EMBO J"},{"issue":"5","key":"2024051811050672000_2023.02.24.529893v4.50","doi-asserted-by":"crossref","first-page":"e1511206","DOI":"10.1080\/23723556.2018.1511206","article-title":"Cdk6: At the interface of Rb and p53","volume":"5","year":"2018","journal-title":"Mol Cell Oncol"},{"issue":"1","key":"2024051811050672000_2023.02.24.529893v4.51","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1038\/s41598-020-60430-7","article-title":"Taurine Induces an Ordered but Functionally Inactive Conformation in Intrinsically Disordered Casein Proteins","volume":"10","year":"2020","journal-title":"Sci Rep"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.02.24.529893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:19:09Z","timestamp":1768450749000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2023.02.24.529893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1101\/2023.02.24.529893","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.3390\/nu16121816","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,2,27]]},"subtype":"preprint"}}